284 related articles for article (PubMed ID: 31116417)
1. Targeting the site encoded by SERPINA1*E342K for treating alpha-1 antitrypsin deficiency-associated liver diseases.
Zhang X; Pham K; Li D; Schutte RJ; Brantly M; Liu C; Ostrov DA
FEBS Lett; 2019 Jul; 593(14):1849-1862. PubMed ID: 31116417
[TBL] [Abstract][Full Text] [Related]
2. Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity.
Laffranchi M; Berardelli R; Ronzoni R; Lomas DA; Fra A
Hum Mol Genet; 2018 May; 27(10):1785-1793. PubMed ID: 29538751
[TBL] [Abstract][Full Text] [Related]
3. The pathological Trento variant of alpha-1-antitrypsin (E75V) shows nonclassical behaviour during polymerization.
Miranda E; Ferrarotti I; Berardelli R; Laffranchi M; Cerea M; Gangemi F; Haq I; Ottaviani S; Lomas DA; Irving JA; Fra A
FEBS J; 2017 Jul; 284(13):2110-2126. PubMed ID: 28504839
[TBL] [Abstract][Full Text] [Related]
4. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.
Hazari YM; Bashir A; Habib M; Bashir S; Habib H; Qasim MA; Shah NN; Haq E; Teckman J; Fazili KM
Mutat Res Rev Mutat Res; 2017 Jul; 773():14-25. PubMed ID: 28927525
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Novel Missense Variants of SERPINA1 Gene Causing Alpha-1 Antitrypsin Deficiency.
Matamala N; Lara B; Gomez-Mariano G; Martínez S; Retana D; Fernandez T; Silvestre RA; Belmonte I; Rodriguez-Frias F; Vilar M; Sáez R; Iturbe I; Castillo S; Molina-Molina M; Texido A; Tirado-Conde G; Lopez-Campos JL; Posada M; Blanco I; Janciauskiene S; Martinez-Delgado B
Am J Respir Cell Mol Biol; 2018 Jun; 58(6):706-716. PubMed ID: 29232161
[TBL] [Abstract][Full Text] [Related]
6. A Novel Small Molecule Inhibits Intrahepatocellular Accumulation of Z-Variant Alpha 1-Antitrypsin In Vitro and In Vivo.
Zhang X; Pham K; Li D; Schutte RJ; Gonzalo DH; Zhang P; Oshins R; Tan W; Brantly M; Liu C; Ostrov DA
Cells; 2019 Dec; 8(12):. PubMed ID: 31817705
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin ligase SYVN1/HRD1 facilitates degradation of the SERPINA1 Z variant/α-1-antitrypsin Z variant via SQSTM1/p62-dependent selective autophagy.
Feng L; Zhang J; Zhu N; Ding Q; Zhang X; Yu J; Qiang W; Zhang Z; Ma Y; Huang D; Shen Y; Fang S; Yu Y; Wang H; Shen Y
Autophagy; 2017 Apr; 13(4):686-702. PubMed ID: 28121484
[TBL] [Abstract][Full Text] [Related]
8. Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency.
Kueppers F; Andrake MD; Xu Q; Dunbrack RL; Kim J; Sanders CL
BMC Med Genet; 2019 Jul; 20(1):125. PubMed ID: 31307431
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Lipid Profiling Reveals Major Differences between Liver Organoids with Normal Pi*M and Deficient Pi*Z Variants of Alpha-1-antitrypsin.
Pérez-Luz S; Lalchandani J; Matamala N; Barrero MJ; Gil-Martín S; Saz SR; Varona S; Monzón S; Cuesta I; Justo I; Marcacuzco A; Hierro L; Garfia C; Gomez-Mariano G; Janciauskiene S; Martínez-Delgado B
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569847
[TBL] [Abstract][Full Text] [Related]
10. Aberrant disulphide bonding contributes to the ER retention of alpha1-antitrypsin deficiency variants.
Ronzoni R; Berardelli R; Medicina D; Sitia R; Gooptu B; Fra AM
Hum Mol Genet; 2016 Feb; 25(4):642-50. PubMed ID: 26647313
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology of alpha 1-antitrypsin deficiency and its significance to clinical medicine.
Kalsheker NA
QJM; 1994 Nov; 87(11):653-8. PubMed ID: 7820538
[TBL] [Abstract][Full Text] [Related]
12. Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations.
Greene CM; Miller SD; Carroll T; McLean C; O'Mahony M; Lawless MW; O'Neill SJ; Taggart CC; McElvaney NG
J Inherit Metab Dis; 2008 Feb; 31(1):21-34. PubMed ID: 18193338
[TBL] [Abstract][Full Text] [Related]
13. Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.
Teckman JH
COPD; 2013 Mar; 10 Suppl 1():35-43. PubMed ID: 23527737
[TBL] [Abstract][Full Text] [Related]
14. Alpha(1)-antitrypsin deficiency, liver disease and emphysema.
Parfrey H; Mahadeva R; Lomas DA
Int J Biochem Cell Biol; 2003 Jul; 35(7):1009-14. PubMed ID: 12672469
[TBL] [Abstract][Full Text] [Related]
15. α1-Antitrypsin deficiency.
Greene CM; Marciniak SJ; Teckman J; Ferrarotti I; Brantly ML; Lomas DA; Stoller JK; McElvaney NG
Nat Rev Dis Primers; 2016 Jul; 2():16051. PubMed ID: 27465791
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice.
Shen S; Sanchez ME; Blomenkamp K; Corcoran EM; Marco E; Yudkoff CJ; Jiang H; Teckman JH; Bumcrot D; Albright CF
Hum Gene Ther; 2018 Aug; 29(8):861-873. PubMed ID: 29641323
[TBL] [Abstract][Full Text] [Related]
17. Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization.
Fra AM; Gooptu B; Ferrarotti I; Miranda E; Scabini R; Ronzoni R; Benini F; Corda L; Medicina D; Luisetti M; Schiaffonati L
PLoS One; 2012; 7(6):e38405. PubMed ID: 22723858
[TBL] [Abstract][Full Text] [Related]
18. Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort.
Clark VC; Marek G; Liu C; Collinsworth A; Shuster J; Kurtz T; Nolte J; Brantly M
J Hepatol; 2018 Dec; 69(6):1357-1364. PubMed ID: 30138687
[TBL] [Abstract][Full Text] [Related]
19. CHOP and c-JUN up-regulate the mutant Z α
Attanasio S; Ferriero R; Gernoux G; De Cegli R; Carissimo A; Nusco E; Campione S; Teckman J; Mueller C; Piccolo P; Brunetti-Pierri N
J Biol Chem; 2020 Sep; 295(38):13213-13223. PubMed ID: 32723872
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanism of Z α1-Antitrypsin Deficiency.
Huang X; Zheng Y; Zhang F; Wei Z; Wang Y; Carrell RW; Read RJ; Chen GQ; Zhou A
J Biol Chem; 2016 Jul; 291(30):15674-86. PubMed ID: 27246852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
